Laboratory Corporation of America Holdings (LH)

Total asset turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 12,901,700 15,811,000 15,621,000 15,510,300 15,632,000 13,745,500 14,941,300 15,859,000 16,120,900 16,554,600 16,388,100 15,316,200 13,978,500 12,442,100 11,474,500 11,587,400 11,554,800 11,388,900 11,291,700 11,276,300
Total assets US$ in thousands 16,725,100 16,886,000 17,718,700 20,200,000 20,155,100 19,826,000 20,403,100 20,728,400 20,385,400 20,866,500 20,417,100 20,417,100 20,071,700 18,739,600 17,849,100 17,298,400 18,046,400 17,847,800 17,744,400 16,970,800
Total asset turnover 0.77 0.94 0.88 0.77 0.78 0.69 0.73 0.77 0.79 0.79 0.80 0.75 0.70 0.66 0.64 0.67 0.64 0.64 0.64 0.66

December 31, 2023 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $12,901,700K ÷ $16,725,100K
= 0.77

The total asset turnover ratio of Laboratory Corp. Of America Holdings has shown variability over the past eight quarters. The ratio ranged from 0.73 to 0.80 during this period, indicating how effectively the company generates revenue relative to its total assets.

A higher total asset turnover ratio typically suggests that the company is efficient in utilizing its assets to generate sales. In this case, the company's total asset turnover has generally been within a narrow range, oscillating around 0.77, which indicates a consistent level of asset utilization efficiency.

However, it is essential to note that a single ratio cannot provide a complete picture of a company's financial health. Further analysis and comparison with industry benchmarks or historical data could provide more insights into Laboratory Corp. Of America Holdings' operational efficiency and asset utilization performance.


Peer comparison

Dec 31, 2023

Company name
Symbol
Total asset turnover
Laboratory Corporation of America Holdings
LH
0.77
Fulgent Genetics Inc
FLGT
0.23
Quest Diagnostics Incorporated
DGX
0.65
RadNet Inc
RDNT
0.60